MCK McKesson Corporation

McKesson Corporation to Present at the 25th Annual Credit Suisse Healthcare Conference

McKesson Corporation (NYSE:MCK) today announced that John Hammergren, chairman and chief executive officer, will present at the 25th Annual Credit Suisse Healthcare Conference in Scottsdale at 10:30 a.m. MT on Tuesday, November 8, 2016. Audio webcasts will be available live and archived on the company’s Investor Relations website at http://investor.mckesson.com. A complete listing of upcoming events for the investment community is available on the company’s Investor Relations website.

About McKesson Corporation

McKesson Corporation, currently ranked 5th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit www.mckesson.com.

EN
20/10/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on McKesson Corporation

McKesson Corporation: Update to credit analysis

McKesson's reflects its position as one of the largest drug distributors in the US, as wells as its modest financial leverage, partially offset by low margins and high customer concentration

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of McKesson Corporation and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 18 November 2025 in which we reassessed the appropriateness of the ratings in the cont...

Mckesson Corp: 1 director

A director at Mckesson Corp sold 329 shares at 861.630USD and the significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of McKesson Corporation and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 25 February 2025 in which we reassessed the appropriateness of the ratings in the cont...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch